hat
bay konsantrasyon relativman ba a nan ki sa a dwòg yo jwenn (50 mg / mL), dòz pi wo a 400 mg yo pa souvan aplike. Olye de sa, se dwòg la souvan anpile ak yon lòt ajan, anjeneral, yon Androjenèn tankou yon testostewòn injectable, ki ede tou konpare nivo a trè ki ba nan androgenicity nan nandrolon. Yon esteroyid oral ak pwononse androgenicity, tankou methandrostenolòn oswa oxymetholone, se pafwa itilize kòm byen, men yo pral prezante tou kèk hepatotoxicity epi yo gen yon efè pi fò sou lipid serom (negatif).
eng
given the relatively low concentration in which this drug is found (50 mg/mL), doses above 400 mg are not commonly applied. Instead, the drug is often stacked with another agent, usually an androgen such as an injectable testosterone, which also helps offset the very low level of androgenicity of nandrolone. An oral steroid with pronounced androgenicity, such as methandrostenolone or oxymetholone, is sometimes used as well, but will also present some hepatotoxicity and have a stronger effect on serum lipids (negatively).